» Articles » PMID: 31775233

Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity

Overview
Specialty Pharmacology
Date 2019 Nov 29
PMID 31775233
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Gentamicin is a potent antibiotic with a nephrotoxicity drawback which limits its use. D-α-tocopherol polyethylene glycol succinate (α-tocopherol) is widely used as a surfactant and have potent antioxidant properties. This study aimed to assess the protective effect of α-tocopherol on gentamicin-induced nephrotoxicity by loading gentamicin on nanostructured lipid carriers (NLC). In vivo, the product was administered intravenously to three groups of rabbits (control, gentamicin and gentamicin/α-tocopherol NLC) for 10 consecutive days. Blood was collected on days 1, 5 and 10 to assess renal function. A significant difference in all plasma parameters related to kidney function were observed in the gentamicin group compared to the control by day 5 and 10, confirming the nephrotoxicity effect. On the other hand, the same parameter levels of the NLC group were significantly different compared to the gentamicin group, confirming the protective effect on kidney function. Gentamicin also caused significant decreases in plasma levels of glutathione sulfhydryl (GSH) and superoxide dismutase (SOD) activity. However, gentamicin-α-tocopherol NLC significantly elevates both plasma levels of GSH as well as SOD activity. The present work indicates that, loading of gentamicin on NLC by using α-tocopherol, is an innovative strategy to protect against aminoglycoside-induced nephrotoxicity due to its antioxidant activity.

Citing Articles

Biopolymer-Based Nanosystems: Potential Novel Carriers for Kidney Drug Delivery.

Li H, Dai W, Xiao L, Sun L, He L Pharmaceutics. 2023; 15(8).

PMID: 37631364 PMC: 10459991. DOI: 10.3390/pharmaceutics15082150.


Curcumin and Vitamin C Attenuate Gentamicin-Induced Nephrotoxicity by Modulating Distinctive Reactive Species.

Tomsa A, Rachisan A, Pandrea S, Benea A, Uifalean A, Toma C Metabolites. 2023; 13(1).

PMID: 36676974 PMC: 9866787. DOI: 10.3390/metabo13010049.


Antibacterial Efficacies of Nanostructured Aminoglycosides.

Bera S, Mondal D ACS Omega. 2022; 7(6):4724-4734.

PMID: 35187293 PMC: 8851436. DOI: 10.1021/acsomega.1c04399.


Cinnamic acid ameliorate gentamicin-induced liver dysfunctions and nephrotoxicity in rats through induction of antioxidant activities.

Babaeenezhad E, Nouryazdan N, Nasri M, Ahmadvand H, Moradi Sarabi M Heliyon. 2021; 7(7):e07465.

PMID: 34278037 PMC: 8264605. DOI: 10.1016/j.heliyon.2021.e07465.

References
1.
Ramsammy L, Ling K, Josepovitz C, Levine R, Kaloyanides G . Effect of gentamicin on lipid peroxidation in rat renal cortex. Biochem Pharmacol. 1985; 34(21):3895-900. DOI: 10.1016/0006-2952(85)90441-1. View

2.
Nishikimi M, Appaji N, Yagi K . The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 1972; 46(2):849-54. DOI: 10.1016/s0006-291x(72)80218-3. View

3.
Fang C, Al-Suwayeh S, Fang J . Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat Nanotechnol. 2012; 7(1):41-55. View

4.
Adi P, Burra S, Vataparti A, Matcha B . Calcium, zinc and vitamin E ameliorate cadmium-induced renal oxidative damage in albino Wistar rats. Toxicol Rep. 2017; 3:591-597. PMC: 5616016. DOI: 10.1016/j.toxrep.2016.07.005. View

5.
Elsayed M, Elkomy A, Gaballah M, Elbadawy M . Nephrotoxicity of cefepime: A new cephalosporin antibiotic in rats. J Pharmacol Pharmacother. 2014; 5(1):33-8. PMC: 3917163. DOI: 10.4103/0976-500X.124419. View